This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Santhosh Kumar Chittimalla: Innovator in Therapeutic Compounds
Introduction
Santhosh Kumar Chittimalla is a notable inventor based in Singapore, recognized for his contributions to the field of therapeutic agents. His innovative work focuses on developing compounds that target specific diseases, particularly those related to the Axl receptor.
Latest Patents
Santhosh holds a patent for a pyrrolo pyrimidine derivative, which is represented by a general formula that incorporates a pyridone ring structure into the pyrrolo pyrimidine skeleton. This compound exhibits strong Axl inhibitory activity, making it a potential therapeutic agent for various Axl-related diseases. These diseases include cancers such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, as well as kidney diseases, immune system diseases, and circulatory system diseases. He has 1 patent to his name.
Career Highlights
Santhosh Kumar Chittimalla is currently employed at Ono Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the search for effective treatments for serious health conditions.
Collaborations
Santhosh collaborates with esteemed colleagues, including Takayuki Inukai and Jun Takeuchi, who contribute to his research endeavors and help drive innovation in the pharmaceutical field.
Conclusion
Santhosh Kumar Chittimalla's work exemplifies the impact of innovative research in developing therapeutic agents for critical diseases. His contributions are significant in the ongoing battle against various health challenges.